Cas:72732-56-0 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine manufacturer & supplier

Chemical Name:6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine

CAS.NO:72732-56-0

Synonyms:6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine;Piritrexime [French];BW-301U;2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d ]pyrimidine;2,4-diamino-6-(2,5-dimethoxybenzyl)-2-methylpyrido[2,3-d]pyrimidine;Piritrexim;Piritrexima [Spanish];Piritreximum [Latin]

Molecular Formula:C₁₇H₁₉N₅O₂

Molecular Weight:325.36500

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:603.315ºC at 760 mmHg

Density:1.294g/cm3

Index of Refraction:1.674

PSA:109.17000

Exact Mass:325.15400

LogP:3.26800

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Piritreximum [Latin] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Piritrexim Use and application,Piritrexime [French] technical grade,usp/ep/jp grade.

Related News: What is the difference? Raw material refers to chemical compounds that are used as a base to make an API. 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine manufacturer What is the difference? Raw material refers to chemical compounds that are used as a base to make an API. 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine supplier But it has been barred from that body as Beijing has increased pressure on Taiwan under President Tsai Ing-wen, who is skeptical about closer ties with China. 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine vendor Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine factory Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies.